8-oxo-7,8-dihydroguanosine
Showing 1 - 25 of >10,000
Diabetes, Type 2 Trial in Hellerup (Empagliflozin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Empagliflozin
- Placebo
-
Hellerup, DenmarkCenter for Diabetes Research, Gentofte Hospital
Jun 9, 2021
Nursing Students Trial (4-7-8 Breathing Exercise Training)
Not yet recruiting
- Nursing Students
- 4-7-8 Breathing Exercise Training
- (no location specified)
Oct 27, 2023
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (Palbociclib, Tazemetostat,
Not yet recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Palbociclib
- +4 more
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Jan 13, 2023
Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)
Not yet recruiting
- Head and Neck Neoplasms
- TransCon TLR7/8 Agonist
- +2 more
- (no location specified)
Aug 4, 2023
Pain Trial in Vienna (Room temperature, Cold temperature, Lidocain)
Not yet recruiting
- Pain
- Room temperature
- +6 more
-
Vienna, AustriaMedical University of Vienna
Jul 6, 2023
Postoperative Complications Trial in Erzurum (The deep breathing group, 4-7-8 breathing technique)
Completed
- Postoperative Complications
- The deep breathing group
- 4-7-8 breathing technique
-
Erzurum, Palandöken, TurkeyAtatürk University
Aug 8, 2022
Hepatocellular Carcinoma Trial (Atezolizumab, Bevacizumab)
Not yet recruiting
- Hepatocellular Carcinoma
- (no location specified)
Oct 18, 2023
Non-Metastatic Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 Trial in Los Angeles (7
Recruiting
- Non-Metastatic Prostate Carcinoma
- +9 more
- 7 Tesla Magnetic Resonance Imaging
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 6, 2022
Non Small Cell Lung Cancer, NSCLC, Stage III, Nsclc Trial in Stanford (Durvalumab, Carboplatin, Pemetrexed)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Durvalumab
- +5 more
-
Stanford, CaliforniaStanford University
Oct 27, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Columbus
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Natural Killer Cell Therapy
- Temozolomide
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 28, 2022
Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v8 Trial in
Recruiting
- Metastatic Salivary Gland Carcinoma
- +5 more
- Pembrolizumab
- Pemetrexed Disodium
-
Scottsdale, Arizona
- +2 more
Mar 15, 2022
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Follicular Lymphoma, Recurrent Indolent Adult Non-Hodgkin Lymphoma Trial in
Suspended
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +7 more
- Venetoclax
- +3 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 20, 2023
Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Active, not recruiting
- Anatomic Stage IIB Breast Cancer AJCC v8
- +19 more
-
Gilbert, Arizona
- +4 more
Dec 6, 2022
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker
Recruiting
- BRCA1 Gene Mutation
- +19 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
New Brunswick, New Jersey
- +1 more
Nov 16, 2022
Stroke, Hand Function Trial in Hamilton (Treatment using the MyHand System)
Recruiting
- Stroke
- Hand Function
- Treatment using the MyHand System
-
Hamilton, Ontario, CanadaAimee Nelson
Mar 31, 2023
The Impact of Opioid and Cannabis Exposure on Fetal Growth
Recruiting
- Pregnancy Related
- +3 more
-
Hamilton, Ontario, Canada
- +4 more
Jun 2, 2023
Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial (procedure, dietary
Not yet recruiting
- Stage I Prostate Cancer AJCC v8
- +3 more
- Biospecimen Collection
- +5 more
- (no location specified)
Apr 20, 2023
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Trial
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Biospecimen Collection
- +9 more
- (no location specified)
Oct 10, 2023
Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8 Trial in Chicago (procedure,
Not yet recruiting
- Prostate Adenocarcinoma
- +3 more
- Biopsy of Prostate
- +6 more
-
Chicago, IllinoisNorthwestern University
May 9, 2023
IL-8+ naïve T Cells as a Biomarker for Thymoma Identification
Not yet recruiting
- Thymoma
- level of IL-8+ initial T cells
- (no location specified)
Jul 23, 2022
Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic
Not yet recruiting
- Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8
- +3 more
- Biospecimen Collection
- +7 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Nov 1, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Los Angeles
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Magnetic Resonance Imaging using 7 Tesla MRI
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 12, 2022
Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally,
Completed
- Smallpox
- +3 more
- NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally
- +5 more
-
Novosibirsk, Koltsovo, Novosibirsk Region, Russian FederationFederal State Budgetary Healthcare Institution - Medical and San
Jul 27, 2023
Extensive Stage Lung Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Recurrent Lung Small Cell Carcinoma Trial in
Recruiting
- Extensive Stage Lung Small Cell Carcinoma
- +5 more
- Atezolizumab
- Temozolomide
-
Indianapolis, Indiana
- +2 more
Oct 26, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in San Francisco (drug,
Withdrawn
- Lung Non-Small Cell Carcinoma
- +9 more
- Cisplatin
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 17, 2022